These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 5794816)

  • 1. Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine.
    Saidi S; Naficy K
    Am J Dis Child; 1969 Aug; 118(2):209-12. PubMed ID: 5794816
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined live measles, mumps, and rubella virus vaccines.
    Buynak EB; Weibel RE; Whitman JE; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(12):2259-62. PubMed ID: 5818433
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined live measles, mumps, rubella vaccine. Immunological response.
    Krugman S; Muriel G; Fontana VJ
    Am J Dis Child; 1971 May; 121(5):380-1. PubMed ID: 5091532
    [No Abstract]   [Full Text] [Related]  

  • 4. Intranasal vaccination with RA 27-3 attenuated rubella virus.
    Puschak R; Young M; McKee TV; Plotkin SA
    J Pediatr; 1971 Jul; 79(1):55-60. PubMed ID: 5091268
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined live measles-rubella virus vaccine. Findings in clinical laboratory studies.
    Villarejos VM; Arguedas JA; Buynak EB; Weibel RE; Stokes J; Hilleman MR
    J Pediatr; 1971 Oct; 79(4):599-604. PubMed ID: 5094254
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination with RA 27-3 rubella vaccine.
    Buser F; Nicolas A; L'Etoile M
    Am J Dis Child; 1971 Jul; 122(1):53-6. PubMed ID: 5567406
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies with rubella vaccine (RA 27-3) using the subcutaneous and intranasal routes.
    Moffat MA; Gould JJ; Forbes FA; Freestone DS; Macdonald A
    Scott Med J; 1972 Apr; 17(4):140-2. PubMed ID: 4554067
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined measles-rubella vaccines. Virus dose and serologic response.
    Landrigan PJ; Murphy KB; Meyer HM; Parkman PD; Eddins DL; Witte JJ
    Am J Dis Child; 1973 Jan; 125(1):65-7. PubMed ID: 4683961
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.
    Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF
    Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.
    Hilleman MR; Buynak EB; Whitman JE; Weibel RW; Stokes J
    Am J Dis Child; 1969 Aug; 118(2):166-71. PubMed ID: 5815860
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of rubella during an epidemic on Taiwan. HPV-77 and RA 27-3 rubella vaccines administered subcutaneously and intranasally HPV-77 vaccine mixed with mumps and-or measles vaccines.
    Beasley RP; Detels R; Kim KS; Gale JL; Lin TL; Grayston JT
    Am J Dis Child; 1969 Aug; 118(2):301-6. PubMed ID: 4893832
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.
    Swartz TA; Klingberg W; Klingberg MA
    Infection; 1974; 2(3):115-7. PubMed ID: 4606362
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunisation of schoolchildren with rubella (RA27-3) vaccine. Intranasal and subcutaneous administration.
    Ingalls TH; Plotkin SA; Philbrook FR; Thompson RF
    Lancet; 1970 Jan; 1(7638):99-101. PubMed ID: 4188770
    [No Abstract]   [Full Text] [Related]  

  • 15. Present status of measles and rubella immunization in the United States: a medical progress report.
    Krugman S
    J Pediatr; 1971 Jan; 78(1):1-16. PubMed ID: 5539083
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental live attenuated rubella virus vaccine. Clinical evaluation of Cendehill strain.
    Prinzie A; Huygelen C; Gold J; Farquhar J; McKee J
    Am J Dis Child; 1969 Aug; 118(2):172-7. PubMed ID: 5794812
    [No Abstract]   [Full Text] [Related]  

  • 17. Attenuated rubella vaccine (HPV-77): evaluation in a large controlled trial.
    Lipman RP; Bethel MB; Wooten JH; Levine RH; Pagano JS
    Am J Public Health; 1971 Jul; 61(7):1392-402. PubMed ID: 4935166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and serological studies on live attenuated rubella virus vaccines used alone and in conjugation with measles vaccines].
    Tsuji A
    Kansenshogaku Zasshi; 1970 Mar; 43(12):394-408. PubMed ID: 4987126
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination of adults with Wistar RA 27/3 rubella vaccine.
    Freestone DS; Prydie J; Smith SG; Laurence G
    J Hyg (Lond); 1971 Sep; 69(3):471-7. PubMed ID: 5285946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of RA 27-3 rubella vaccine.
    Schiff GM; Linnemann CC; Shea L; Grundy B; Ashe HS
    J Pediatr; 1974 Sep; 85(3):379-81. PubMed ID: 4447664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.